Daesung Microbiological Labs Co Ltd banner
D

Daesung Microbiological Labs Co Ltd
KOSDAQ:036480

Watchlist Manager
Daesung Microbiological Labs Co Ltd
KOSDAQ:036480
Watchlist
Price: 7 560 KRW 2.3% Market Closed
Market Cap: ₩28.7B

Balance Sheet

Balance Sheet Decomposition
Daesung Microbiological Labs Co Ltd

Balance Sheet
Daesung Microbiological Labs Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2001 Dec-2002 Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
913
604
607
557
578
586
802
815
692
1 229
608
1 302
1 356
1 420
6 522
4 444
5 247
4 943
8 252
5 212
4 395
3 852
4 362
3 630
Cash Equivalents
913
604
607
557
578
586
802
815
692
1 229
608
1 302
1 356
1 420
6 522
4 444
5 247
4 943
8 252
5 212
4 395
3 852
4 362
3 630
Short-Term Investments
3 811
3 077
3 424
3 286
3 140
3 287
3 910
4 141
4 342
1 510
1 238
1 061
990
1 054
1 561
5 452
3 918
6 231
4 252
4 840
5 539
9 007
7 365
5 423
Total Receivables
4 675
3 622
3 630
3 427
3 797
4 234
4 533
3 759
3 509
4 335
4 294
3 660
3 977
3 432
3 284
4 128
3 187
3 863
2 970
3 892
3 114
3 251
4 285
3 958
Accounts Receivables
4 650
3 597
3 604
3 401
3 781
4 221
4 523
3 758
3 509
4 101
4 176
3 504
3 977
3 432
3 284
4 128
2 971
3 863
2 970
3 730
3 058
3 196
4 285
3 958
Other Receivables
25
25
26
26
16
13
10
1
0
234
118
156
0
0
0
0
216
0
0
162
56
56
0
0
Inventory
2 325
3 265
3 190
3 338
3 053
3 014
3 026
3 776
4 237
4 607
4 733
4 525
6 352
5 839
5 543
6 465
6 786
7 929
9 266
9 197
10 614
11 641
12 499
10 481
Other Current Assets
78
95
74
146
105
96
214
87
69
64
40
45
45
72
59
84
32
34
299
617
60
939
205
149
Total Current Assets
11 803
10 663
10 925
10 754
10 673
11 217
12 484
12 579
12 848
11 746
10 913
10 593
12 720
11 817
16 970
20 573
19 170
23 000
25 039
23 757
23 722
28 690
28 717
23 641
PP&E Net
5 966
7 083
6 567
7 421
8 519
8 077
7 987
7 530
7 361
11 872
13 972
12 989
14 675
14 199
13 444
12 785
13 021
12 634
23 147
35 285
35 846
33 303
32 124
31 944
PP&E Gross
5 966
7 083
6 567
7 421
8 519
8 077
7 987
7 530
7 361
0
0
0
0
0
0
0
0
0
23 147
35 285
0
0
32 124
31 944
Accumulated Depreciation
2 262
2 798
3 530
3 950
4 423
4 766
4 993
5 315
5 753
0
0
0
0
0
0
0
0
0
171
171
0
0
82
142
Intangible Assets
248
156
170
222
444
537
526
622
662
860
793
772
794
758
994
1 237
1 282
1 192
1 132
1 204
1 074
874
687
548
Note Receivable
50
125
101
106
8
34
93
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
60
210
164
68
294
244
91
385
382
352
505
455
353
493
461
425
608
636
946
1 342
1 327
1 256
1 498
1 310
Other Long-Term Assets
321
354
497
565
566
566
590
733
642
316
400
683
403
524
550
588
702
637
763
675
651
987
1 265
936
Total Assets
18 448
N/A
18 592
+1%
18 423
-1%
19 137
+4%
20 504
+7%
20 675
+1%
21 771
+5%
21 851
+0%
21 894
+0%
25 145
+15%
26 583
+6%
25 492
-4%
28 945
+14%
27 791
-4%
32 419
+17%
35 607
+10%
34 782
-2%
38 098
+10%
51 028
+34%
62 263
+22%
62 620
+1%
65 109
+4%
64 290
-1%
58 379
-9%
Liabilities
Accounts Payable
1 554
1 224
975
944
1 111
908
923
976
631
669
770
416
2 197
1 425
2 450
2 563
1 203
1 848
1 813
1 237
769
978
1 543
1 318
Accrued Liabilities
180
309
249
216
330
352
299
277
309
488
457
518
526
736
723
545
626
563
1 014
2 148
2 081
2 681
821
801
Short-Term Debt
0
0
0
0
0
0
0
0
0
353
1 682
810
2 041
1 800
1 800
800
800
700
700
878
700
2 000
5 319
1 000
Current Portion of Long-Term Debt
120
120
80
67
0
75
300
300
300
300
772
1 093
1 093
0
98
285
274
125
0
172
1 676
4 491
2 277
1 007
Other Current Liabilities
1 143
618
117
107
408
295
642
174
137
127
119
64
234
318
841
548
176
477
242
143
89
461
438
404
Total Current Liabilities
2 997
2 272
1 421
1 334
1 849
1 630
2 164
1 727
1 377
1 937
3 800
2 901
6 091
4 278
5 912
4 740
3 080
3 713
3 769
4 578
5 315
10 611
10 398
4 530
Long-Term Debt
268
147
67
733
1 500
1 425
1 125
825
525
2 618
2 733
2 140
2 242
1 195
98
337
125
0
11 143
20 852
19 977
15 538
16 415
18 420
Deferred Income Tax
261
452
522
420
167
60
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
606
527
591
537
517
381
269
165
150
150
220
720
896
1 180
1 315
1 519
1 281
1 377
1 400
521
325
123
128
279
Total Liabilities
4 132
N/A
3 398
-18%
2 601
-23%
3 024
+16%
4 034
+33%
3 495
-13%
3 558
+2%
2 716
-24%
2 053
-24%
4 705
+129%
6 753
+44%
5 761
-15%
9 229
+60%
6 653
-28%
7 325
+10%
6 596
-10%
4 486
-32%
5 089
+13%
16 312
+221%
25 952
+59%
25 616
-1%
26 272
+3%
26 942
+3%
23 230
-14%
Equity
Common Stock
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
1 900
Retained Earnings
6 032
7 053
7 681
7 972
8 330
9 039
10 072
10 994
11 701
12 302
11 697
11 591
11 575
12 997
16 952
20 870
22 155
24 868
26 571
28 167
28 859
30 693
29 204
27 005
Additional Paid In Capital
6 385
6 241
6 241
6 241
6 241
6 241
6 241
6 241
6 241
6 241
6 241
6 241
6 241
6 241
6 241
6 241
6 241
6 241
3 085
3 085
3 085
3 085
3 085
3 085
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3 160
3 160
3 160
3 160
3 160
3 160
Other Equity
0
0
0
0
0
0
0
0
0
4
8
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Equity
14 317
N/A
15 194
+6%
15 822
+4%
16 113
+2%
16 471
+2%
17 180
+4%
18 213
+6%
19 135
+5%
19 842
+4%
20 439
+3%
19 830
-3%
19 732
0%
19 716
0%
21 138
+7%
25 093
+19%
29 012
+16%
30 296
+4%
33 009
+9%
34 715
+5%
36 311
+5%
37 004
+2%
38 837
+5%
37 349
-4%
35 149
-6%
Total Liabilities & Equity
18 448
N/A
18 592
+1%
18 423
-1%
19 137
+4%
20 504
+7%
20 675
+1%
21 771
+5%
21 851
+0%
21 894
+0%
25 145
+15%
26 583
+6%
25 492
-4%
28 945
+14%
27 791
-4%
32 419
+17%
35 607
+10%
34 782
-2%
38 098
+10%
51 028
+34%
62 263
+22%
62 620
+1%
65 109
+4%
64 290
-1%
58 379
-9%
Shares Outstanding
Common Shares Outstanding
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett